Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06694714 · ClinicalTrials.gov registry record · Phase 4

Split Face Study of the Duration of Local Anesthetics - Fourth Arm

A Phase 4 study of Anesthesia, Local, sponsored by Weill Medical College of Cornell University.

Recruiting
Registry status
Phase 4
Development phase
35
Enrollment target
1
Study location

NCT06694714: Recruiting Phase 4 study of Anesthesia, Local, sponsored by Weill Medical College of Cornell University.

NCT06694714 is a Phase 4 study of Anesthesia, Local that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 35 participants, below the 81-participant average among 18 other Anesthesia, Local trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06694714, a Phase 4 study of Anesthesia, Local, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.

RECRUITING
Registry status
Phase 4
Development phase
35 participants
Enrollment target
1
Study location

Study Summary

This is a research study to compare how long injectable pain medications (anesthetics) commonly used in dermatologic surgery are effective for. The investigators will investigate the role of anesthetic volume on the duration of action at highly vascular sites.

Primary Outcome

To determine whether the time to return to baseline sensation differs significantly between each pair of anesthetics, the investigators will measure the time to return to baseline sensation at each anesthetized site by asking participants at 15 minute intervals if they can feel a sharp sensation at the site. Sterile needles will be used. The return of the sensitivity will be determined using binary outcomes (yes/no) and recorded on a standardized template. The maximum difference in anesthetic du

Conditions Studied

Interventions

  • DRUG 0.5 ml lidocaine + epinephrine 1:100,000
  • DRUG 1.0 ml lidocaine + epinephrine 1:100,000

Study Locations (1)

New York

  • Weill Cornell Medicine - New York

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2025-01-21
Est. Completion 2027-06-01
Phase Phase 4

What NCT06694714 shows while recruiting

NCT06694714 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 81-participant average among 18 other Anesthesia, Local trials with a reported enrollment target (57% lower).

The record links to 1 condition, with Anesthesia, Local appearing as the primary indexed condition, and to 2 interventions - of which 0.5 ml lidocaine + epinephrine 1:100,000 is the first listed.

NCT06694714 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT06694714 about?

NCT06694714 is a clinical study titled "Split Face Study of the Duration of Local Anesthetics - Fourth Arm". This is a research study to compare how long injectable pain medications (anesthetics) commonly used in dermatologic surgery are effective for. The investigators will investigate the role of anesthetic volume on the duration of action at highly vascular sites.

What is the current status of trial NCT06694714?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 35 participants. The study started on 2025-01-21. Estimated completion is 2027-06-01.

What conditions does trial NCT06694714 study?

This clinical trial studies the following conditions: Anesthesia, Local.

What interventions are being tested in trial NCT06694714?

The interventions under investigation include: 0.5 ml lidocaine + epinephrine 1:100,000 (DRUG), 1.0 ml lidocaine + epinephrine 1:100,000 (DRUG).

Who is sponsoring clinical trial NCT06694714?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06694714 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anesthesia, Local

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06694714's enrollment target sits among peer trials

35 15th of 18 higher than 4 of 18 other Anesthesia, Local trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anesthesia, Local trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01697371 · 35 participants · NA

    Proton Therapy in the Treatment of Liver Metastases

  • NCT01940757 · 35 participants · Phase 1

    Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae

  • NCT02235857 · 35 participants · NA

    Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children

  • NCT02637934 · 35 participants · Phase 1

    Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06694714, the US trial registry maintained by the National Library of Medicine. NCT06694714 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.